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Abstract
Identification of epitopes targeted by antibodies (B cell epitopes) is of critical importance for
the development of many diagnostic and therapeutic tools. For clinical usage, such epitopes
must be extensively characterized in order to validate specificity and to document potential
cross-reactivity.
B cell epitopes are typically classified as either linear epitopes, i.e. short consecutive seg-
ments from the protein sequence or conformational epitopes adapted through native protein
folding. Recent advances in high-density peptide microarrays enable high-throughput, high-
resolution identification and characterization of linear B cell epitopes. Using exhaustive amino
acid substitution analysis of peptides originating from target antigens, these microarrays can
be used to address the specificity of polyclonal antibodies raised against such antigens con-
taining hundreds of epitopes. However, the interpretation of the data provided in such large-
scale screenings is far from trivial and in most cases it requires advanced computational and
statistical skills. Here, we present an online application for automated identification of linear B
cell epitopes, allowing the non-expert user to analyse peptide microarray data. The application
takes as input quantitative peptide data of fully or partially substituted overlapping peptides
from a given antigen sequence and identifies epitope residues (residues that are significantly
affected by substitutions) and visualize the selectivity towards each residue by sequence logo
plots. Demonstrating utility, the application was used to identify and address the antibody
specificity of 18 linear epitope regions in Human Serum Albumin (HSA), using peptide micro-
array data consisting of fully substituted peptides spanning the entire sequence of HSA and
incubated with polyclonal rabbit anti-HSA (and mouse anti-rabbit-Cy3). The application is
made available at: www.cbs.dtu.dk/services/ArrayPitope.
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Introduction
The highly diverse repertoire of antibodies constitutes a very important component of the
immune-mediated protection against pathogens. The exquisite target specificity and high
affinity of binding make antibodies attractive tools in scientific, diagnostic and therapeutic
applications. Characterization of the specificity of antibodies towards their binding site (epi-
tope) is important for their selection towards intended targets and preventing unintended
cross-reactivity [1].
Protein epitopes are usually classified as linear or conformational, depending on whether
the amino acids comprised are brought together by proximity in the peptide chain or by pro-
tein folding, respectively [2]. The majority of epitopes are thought to be conformational, but
the distinction is not clear-cut since conformational epitopes often contain small segments of
continuous residues able to bind the antibody on their own [3,4]. Since conformational epi-
topes rarely maintain readily detectable binding activity outside the context of the native pro-
tein structure, characterization of the conformational epitopes can be an extremely difficult
task. On the other hand, linear epitopes (and linear segments of conformational epitopes) can
be characterized by studying antibody binding to short peptide fragments of the protein.
Characterization of the specificity of polyclonal antibodies toward any potential linear epi-
tope within an antigen is challenging. Many different methods including solid phase peptide
libraries and phage displayed peptide libraries [5,6] have been used to screen for linear epi-
topes. Although peptide display systems offer high-throughput identification of linear mimo-
topes [7] they have biases with regard to certain sequence populations and selection steps
[6,8,9]. Using synthetic peptides to map target antigens, the mapping resolution depends on
the length and overlap of the analysed peptides as well as subsequent truncations or substitu-
tions, used to fine-map the location of the epitope and the contribution of the individual
amino acids to the antibody binding [10]. Most studies based on synthetic peptides involve
mapping of native-sequence proteins using overlapping peptides of length 15–30 amino acids
[11,12] and some use alanine scans, in which alanine substitutions are introduced in the syn-
thetic peptides to improve mapping resolution [13].
Recent advances in high-density peptide microarrays have enabled parallel synthesis of
hundreds of thousands of peptides [10,14]. Two studies have used peptide microarrays to con-
duct full-resolution epitope mapping using exhaustive single-amino acid substitution analysis
[10,15]. These studies use statistical methods to pinpoint which residues of a given peptide epi-
tope are involved in antibody interaction, by identifying significant changes in signal intensity
upon substitutions relative to the native sequences. By inspecting the individual amino acid
substitutions at the different positions within a given peptide the antibody specificity can be
characterized. However, microarray-driven amino acid substitution analysis can be quite cum-
bersome, e.g. when mapping epitopes in hundreds of proteins this way.
Here, we present ArrayPitope, an automated analysis tool for characterizing and visualizing
the specificity of the epitopes identified through large-scale single-amino acid substitution
analysis of peptides. The tool identifies the contribution of each amino acid residue of the tar-
get protein for recognition of the corresponding antibodies and subsequently incorporates
binding signals from overlapping peptides into one statistical analysis to precisely map the
selectivity of each residue of the target protein involved in the recognition. As an illustration of
the utility of this tool, we apply the method on a full-scale substitution analysis of the 69 kDa
human serum albumin to address the specificities of polyclonal antibodies raised against the
protein. An online implementation of the tool has been made freely available at www.cbs.dtu.
dk/services/ArrayPitope.
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Methods
The method takes quantitative peptide data and a set of protein sequences as input. All pep-
tides are mapped back to the protein sequence including all single-amino acid derivatives of
these peptides. The intensity values of peptides subjected to substitutions are rescaled relative
to the intensity of corresponding native peptide (median is used if multiple copies of native
peptide exist). As such, substitutions giving rise to a lower intensity relative to the native pep-
tide result in substitution values less than 1, and substitutions with no effect on the intensity
takes the substitution value of 1, whereas substitutions giving rise to a higher intensity relative
to the native peptide (also known as heteroclitic responses) takes a substitution value more
than 1. The signal variance is estimated from the pool of native peptides sampling N peptides
using bootstrap method where N is the number of copies of the given native peptide. The algo-
rithm next performs the statistical analyses in two steps: i) first, by calculating the statistical
significance of the mean substitution effects of each position in individual native peptides to
determine which peptide positions are part of the epitope, and next ii) the algorithm incorpo-
rates information from overlapping peptides containing a given position in the mapped pro-
tein and determines the position specific binding selectivity of the antibody. The two steps are
outlined below.
Epitope-calling in individual native peptides
For each native peptide sequence, the substitution values are used to generate a position-spe-
cific scoring matrix (PSSM), in which columns represents positions in the peptide and rows
represents amino acid substitutions. To determine if peptide positions undergoing substitution
lead to a disruption of antibody binding, the importance of each peptide position is inferred by
a Dunnett’s test, i.e. comparing multiple sample means to a control population. Here the mean
substitution value is compared to the theoretical value, μ0 = 1, of no selectivity. When S2 is the
pooled variance of the PSSM, then SEi ¼
ffiffiffiffiffiffiffiffiffiffi
S2=ni
p
is the pooled standard error of the i-th col-
umn of the PSSM, where ni is the number of substitutions in column i of the PSSM. In a com-
plete amino acid substitution analysis ni (and thus SEi) is the same for all positions. The least-
significant-difference (LSD) is computed as:
LSDi ¼ tdSEi:
The critical value td is computed as the quantile for the one-tailed noncentral Dunnett’s test
distribution corresponding to i) a given significance level, ii) the number of groups k, equal to
the peptide length, minus 1 and iii) the number of degrees of freedoms equal to the number of
substitution values minus the length of the peptide (∑ni − k). Peptide positions, where the rela-
tive change in signal exceeds the LSD value, i.e 1-μi> LSDi, are characterized as being part of
the epitope.
Determining the selectivity of positions in overlapping peptides
For each residue in the protein being mapped in overlapping peptides, the algorithm seeks to
determine which amino acid substitutions leads to a significant change in signal intensity rela-
tive to the native amino acid. Here, the substitution values are used to generate a substitution
matrix expressing substitution values of one protein residue being represented in different
positions in the overlapping peptides (see Fig 1 for a schematic illustration of the procedure).
Here, only peptides are included containing protein positions previously identified to be
involved in the epitope.
Peptide Microarray and Epitope Mapping
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A Dunnett’s multiple comparison procedure is used to test which mean, μi (i.e. which
replacing amino acid), that are significantly different from the value 1 of no selectivity. The
LSD of each column of the substitution matrix is calculated as described above for each col-
umn of the PSSM. Protein positions will be reported and visualized, where the relative change
in signal of one or more amino acid substitutions exceeds the LSD value.
If SEi is the pooled standard error of the i-th column of the substitution matrix, then ti = (μi −
μg)/SEi is the t-statistic used to test the departure of the replacing amino acid i relative to the
global mean, μg, of the substitution matrix. Thus, mean substitution values above μg yield positive
t-statistics (amino acids favouring interactions), while substitution values below μg yield negative
t-statistics (amino acids disfavouring interactions). The p-value of the t-statistic is calculated
from the cumulative distribution function for the noncentral Dunnett’s test distribution with
degrees of freedoms equal i) to the number of replacing amino acid (up to 19) and ii) the total
number of substitution values minus the number of replacing amino acids. To visualize the selec-
tivity profile, each protein residue is presented in a logo-plot with the corresponding amino acid
Fig 1. Example of substitution matrix. Figure showing overlapping peptides (left) with the valine (V highlighted in bold) being analyzed for
antibody selectivity. The box contains the substitution values, xi,j, with columns representing the amino acid, i, which substitutes valine and rows
representing the position, j, of the valine in the peptide (illustrated to the left) undergoing substitution. The mean substitution value, μi, of each
replacing amino acid is shown in the bottom row. The global mean, μg, is calculated across all substitution values in the matrix.
doi:10.1371/journal.pone.0168453.g001
Peptide Microarray and Epitope Mapping
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substitutions scored as
si ¼   signðtiÞlog10ðpiÞ;
and subsequently rescaled so that ∑|si| = (1 − μg), consequently making the absolute sum of logo-
heights reflect the mean change caused by substitutions of the native amino acid. To illustrate
this, a sample data is shown in Fig 2, exemplifying two positions with high and low selectivity,
respectively. In Fig 2A, only the native amino acid E (highlighted in solid fill at μ = 1) retains
complete antibody binding (μE 1). The majority of the remaining amino acid substitutions
lead to a decrease in signal and thus lower substitution value. The p-value associated with the
native amino acid E is hence low (p 1), since the departure from the global mean μg is high
(t> 0), leading to a high positive score, sE. The resulting logo-plot is shown in Fig 2C. The native
amino acid employs the largest letter scale, but both the negatively charged amino acid D and
the positively charged amino acids K, H and R employ larger letter scales due to their departure
from μg, in opposite directions. The absolute sum of the logo-plot column corresponds to the
global effect of substitution (1 − μg = 0.60). Fig 2B exemplifies positions with only two amino
acid substitutions affecting the signal. Here, the native amino acid, which also happens to be E
(highlighted in solid fill at μ = 1) will employ a high p-value (p 1), since the substitution value
is close to μg, leading to a low score (sE 0). The resulting logo-plot is shown in Fig 2D. The
absolute sum of the logo-plot column is much smaller in this example (1 − μg = 0.20) and only
substitutions to K and H are affecting the signal, as seen by the relatively large negative scales.
Fig 2. Schematic example of the generation of selectivity logo-plots. Figure showing example of selectivity of two epitope positions in overlapping
peptides upon substitutions with all 19 amino acids. A and B shows illustrative density plots of substitution values taken from a substitution matrix, with the
mean substitution value,.μi, of each replacing amino acid shown in diamond shapes. Filled diamond is the native amino acid (E in both examples). C and D
show the resulting logo-plot of the positions exemplified in A and B, respectively. The logo-plots are made using Seq2Logo [16].
doi:10.1371/journal.pone.0168453.g002
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Results
The ArrayPitope webserver was implemented to perform statistical analyses of the effects of
single-amino acid substitution on a receptor-ligand interaction. Here, the webserver has been
used to automatically map and characterize linear antibody epitopes in the human serum albu-
min (HSA) protein. Quantitative peptide microarray data was obtained from Hansen et al.
[17] consisting of overlapping 15-mer peptides mapping the primary sequence of HSA (uni-
prot P02768) in 50 copies, including one copy of all possible single-amino acid substitutions.
In total, the data consisted of 215,147 peptides. These peptides were measured for response to
a commercially available polyclonal rabbit anti-HSA antibody using a secondary Cy3-conju-
gated goat anti-rabbit IgG, and fluorescence microscopy.
Identifying peptide residues involved in antibody binding
To identify which peptides and peptide residues are involved in epitopes, a complete single-
amino acid substitution analysis was performed by first constructing a position specific scoring
matrix (PSSM) for each overlapping native peptide in the microarray data (see materials and
methods for details). Fig 3 shows such PSSM for the peptide DHVKLVNEVTEFAKT, map-
ping position 62–76 of the primary sequence of HSA. The PSSM contains substitution values
(relative to the native peptide) of all 19 replacing amino acids in all 15 positions of the peptide.
For each PSSM, a Dunnett’s least-significant-difference was calculated for every position in the
peptide, to determine if the mean substitution value is significantly different from the theoreti-
cal value 1 of no selectivity. For the purpose of demonstration, the significance level of 0.0001
was chosen for the following analyses. For the peptide shown in Fig 3, the positions 66–73
(spanning the octamer LVNEVTEF) were each identified to show a significant reduction
(p<0.0001) in binding signal upon substitution.
The first part of the output of the algorithm is a table of all the overlapping peptides map-
ping the target protein(s) with their identified epitope highlighted. A limited part of the output
table for HSA is shown in Table 1, for the peptides spanning the region 56–88 of HSA. The
LVNEVTEF epitope is seen sliding through the overlapping 15-mer peptides. As part of the
epitope leaves the peptide window (at position 67), the median native signal drops to 255 and
new epitope residues are shown to be part of the epitope for the 15-mer VNEVTEFAKTC-
VADE. Some inconsistencies are found among the identified amino acids in overlapping pep-
tides because these positions are only weakly affected by substitutions. Depending on the
inclusion criterion the table shows a total of up to four overlapping epitopes. The results pre-
sented are nearly identical to previous studies made on the same data, using ANOVA-pro-
tected Tukey honest-significant-difference procedure to identify key residues (on the 0.01
significance level) involved in the epitopes of individual peptides [15]. Only the weakly affected
residues fluctuate to a minor degree between the two approaches. A full table for the entire
HSA protein can be found in S1 Table.
Antibody selectivity toward individual residues
The table output above presents a visual overview of the epitope mapping in overlapping pep-
tides and enables the user to observe where one epitope ends and another begins. The output
however, does not elucidate which positions are more selective than others for the antibody
binding. To extract these differences, the algorithm incorporates the substitution values of a
single protein residue from different peptides (native and 19 substitutions) overlapping this
position. Such a substitution matrix is shown for position 518D in Fig 4, highlighting in the
lower row the amino acid replacements with higher (green) or lower (red) substitution values
relative to the global mean, μg = 0.240 (white), of the substitution matrix. Blank rows depict
Peptide Microarray and Epitope Mapping
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the native residue being represented in peptides with residues found to be significantly affected
by substitution. The matrix displays complete selectivity for the native amino acid D (μD
μg), with all 19 amino acid variations disrupting antibody binding in the majority of positions
being represented.
In order to visualize the selectivity, the algorithm constructs logo plots covering all positions
in the target protein. As an example, the logo plot representation of three epitope regions of
HSA (including residues 518D and 520T) is shown in Fig 5. A logo plot of the LEVDETY epi-
tope is shown in Fig 5A. The figure shows amino acid letters in columns representing positions
in the protein. Positions not previously found (using the single peptide analysis) to be signifi-
cantly important for the epitope are shown as blank. The individual letters are log(p) scaled
with positive letters denoting μi> μg and negative letters denoting μi< μg. The absolute height
of each position reflects the mean change (1 − μg) caused by substitutions of the native amino
acid. More details on the calculation of the logo plot and calculation of the position specific
substitution matrices can be found in the methods section. The selectivity logo-plot shows a
strong selectivity in positions 516E, 518D and 519E towards the native negatively charged
amino acids while showing preference for non-polar residues in position 515L and 517V,
small alcohol-containing residues (Serine and Threonine) in position 520T, and aromatic
residues in position 521Y. Moreover, differences in the effect on substitutions of the native
Fig 3. Example of a position specific scoring matrix. The table shows the individual substitution values for
the peptide DHVKLVNEVTEFAKT through all 15 positions (columns) with all 20 amino acids (rows). The last
row shows the mean substitution value of the positions. Blank cells are native amino acids. A Dunnett’s LSD
of 0.1741 was calculated on the chosen p<0.0001 level and cells exceeding this difference are highlighted
with a gray gradient (weak to strong effects). The identified epitope is LVNEVTEF.
doi:10.1371/journal.pone.0168453.g003
Peptide Microarray and Epitope Mapping
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residues can be seen from the absolute height of letters in the logo-plot. Fig 5B and 5C shows
examples of two other epitopes (ELFE-LGEYKFQ and DI-TLSEKERQI) found within peptides
with relatively low binding signal (130 and 176 Au, respectively). A large number of single-
amino acid derivatives of the ELFE-LGEYKFQ epitope share the binding signal of the native
epitope, whereas only a few derivatives of the DI-TLSEKERQI epitope retain antibody bind-
ing. The results show that epitopes giving rise to similar binding signal may employ different
effects upon substitutions (total height of columns in logo plot), and different representations
of the amino acid selectivity. A full logo plot of the entire HSA protein can be found in S1 Fig.
The algorithm identifies a total of 18 HSA epitope regions, as shown in Table 2. Each identi-
fied position has at least one amino acid substitution leading to a significant mean relative
Table 1. Example of target-specific positions of individual peptides. The table shows output of 33 overlapping peptides mapping the positions 56 to 88
of the HSA protein sequence. Positions identified as being important for binding (identified by the Dunnett’s test of complete single-amino acid substitutions at
the p<0.0001 level) are highlighted whereas dashes indicate positions not involved in binding. The median signal of copies of the corresponding native peptide
is shown.
Position Peptide Epitope Native Binding Intensity (Median)
56 QQCPFEDHVKLVNEV - - - - - - - - - - - - - - - 62
57 QCPFEDHVKLVNEVT - - - - - - - - -LVNEV- 156
58 CPFEDHVKLVNEVTE - - - - - - - -LVNEV-E 183
59 PFEDHVKLVNEVTEF - - - - - - -LVNEVTEF 560
60 FEDHVKLVNEVTEFA - - - - - -LVNEVTEF- 584
61 EDHVKLVNEVTEFAK - - - - -LVNEVTEF- - 522
62 DHVKLVNEVTEFAKT - - - -LVNEVTEF- - - 497
63 HVKLVNEVTEFAKTC - - -LVNEVTEF- - - - 441
64 VKLVNEVTEFAKTCV - -LVNEVTEF- - - - - 494
65 KLVNEVTEFAKTCVA -LVNEVTEF- - - - - - 396
66 LVNEVTEFAKTCVAD LVNEVTEF- -T- - - - 473
67 VNEVTEFAKTCVADE - - - -TEF-KTCV- -E 255
68 NEVTEFAKTCVADES - - - -EF-KT-V-DE- 327
69 EVTEFAKTCVADESA - - -EFAKT-V-DE- - 328
70 VTEFAKTCVADESAE - -EF- -T-V-DES- - 328
71 TEFAKTCVADESAEN -EF- -T-V-DES-E- 287
72 EFAKTCVADESAENC - - - - -CV-DESAE-C 350
73 FAKTCVADESAENCD - - - -C-ADESAE-C- 315
74 AKTCVADESAENCDK - - -C-ADESAE-C- - 270
75 KTCVADESAENCDKS - -C-ADESAE-C- - - 284
76 TCVADESAENCDKSL -C- -DESAE-C- - - - 331
77 CVADESAENCDKSLH C-ADESAE-CD- - - - 206
78 VADESAENCDKSLHT - -DESAE- -D- - - - - 151
79 ADESAENCDKSLHTL -DESAE- -D- - - - - - 136
80 DESAENCDKSLHTLF - - - -E- -DKSL-TLF 395
81 ESAENCDKSLHTLFG - - - - - -DKSL-TLF- 355
82 SAENCDKSLHTLFGD - -E- -DKSL-TLF- - 388
83 AENCDKSLHTLFGDK - - - -DKSL-TLF-D- 331
84 ENCDKSLHTLFGDKL - - -DKSL-TLF-D- - 287
85 NCDKSLHTLFGDKLC - -DKSL-TLF-D- - - 199
86 CDKSLHTLFGDKLCT -DKSL-TLF-D- - - - 195
87 DKSLHTLFGDKLCTV DKSL-TLF-D- - - - - 174
88 KSLHTLFGDKLCTVA - - - - - - - - - - - - - - - 44
doi:10.1371/journal.pone.0168453.t001
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Fig 4. Example of selectivity tables. Tables showing substitution values of residue 518D of human serum albumin against all 20 amino acids (columns) and
being represented in 10 out of 15 positions of the overlapping peptides (rows). Entire blank rows depict the native residue being represented in peptides with
no positive signal. Individual blank cells are missing data. The row μ shows the mean substitution value of the replacing amino acids. Here, cells are
highlighted by the effect of substitution as a color gradient from red to green through white, where white corresponds to the global mean, μg, equal to 0.240.
doi:10.1371/journal.pone.0168453.g004
Fig 5. Examples of selectivity profile of epitope. Logo-plot representations of the selectivity of three 15-residue regions of the primary sequence of HSA.
Selectivity is determined by Dunnett’s test on all substitutions of target position, being represented in overlapping peptides. Each letter represents replacing
amino acids and is scaled by log(p), where the p-value is obtained from the Dunnett’s test. Positive letters denotes substitution values above the global mean,
μg, while negative letters denotes substitution values below μg. The absolute height of an entire column represents the average relative change in signal of all
substitutions of target residue. The average signal of native 15-mer peptides containing the epitopes is (A) 489 Au, (B) 130 Au and (C) 176 Au.
doi:10.1371/journal.pone.0168453.g005
Peptide Microarray and Epitope Mapping
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change in signal. The selectivity of the individual positions differs greatly, which can be seen
from the full logo plot of HSA in S1 Fig. Some regions span more than the 15-residue length of
the peptides, and represents overlapping independent epitopes. The boundaries of individual
epitopes are open to subjective evaluation by studying the individual overlapping peptides in
S1 Table, and are not defined automatically by the algorithm.
Two B cell epitopes for HSA have been mapped and are available within the IEDB [18].
Both of these are structural epitopes characterized with a large linear determinants; (E251,
F252, A253, E254, S256, K257) and (S513, A514, L515, E516, E519, T520). Both of these are
accurately captured by the ArrayPitope analysis of the peptide-chip data (see Table 2).
The application was applied to a library of complete single-amino acid substitutions of a
native protein antigen sequences. Amino acid substitutions are a critical requirement of this
algorithm. However, a single-residue scan, such as an alanine scan is sufficient to produce
meaningful sequence logos that can be used to pinpoint non-alanine positions involved in the
epitope. In such case, the substitution matrix in Fig 4 will contain only two columns, and the
Dunnett’s statistical procedure will condense to a Student’s t-test of comparing the mean sub-
stitution value of the replacing amino acid with that of the native amino acid. The sliding
representation of the epitopes (Table 1) will not be produced for this type of data, since the
PSSM of Fig 3 would only include one substitution value for every position, critically lowering
the degrees of freedom used for the Dunnett’s multiple comparison procedure. 13 epitope
regions were found using a limited dataset including only substitutions with alanine (S2
Table). The alanine-only dataset was sufficient to identify 105 (55.9%) out of the 188 epitope
residues found using the exhaustive substitution dataset (data not shown). 11 (10.5%) of the
missed epitope positions can be ascribed to the native residue being alanine. The remaining
missed epitope residues can be ascribed to a general limitation in epitope mapping when solely
using alanine substitutions thus highlighting the value of a complete, exhaustive substitution
strategy.
Table 2. HSA epitopes. Table showing 18 HSA epitope regions identified by the algorithm. Dashes mark gaps of residues with no selectivity. The regions
were identified from the logo plots, and defined as having a minimum of 4 residues and a maximum gap-length of 2 residues.
Range Region
35–45 FKDLGEEN- -A
66–96 LVNEVTEF-KTCVADESAE-CDKSL-TLF-D
101–106 VAT-RE
110–124 E- -DCCAKQEPE- -E
133–145 NPNLPRLV-RPEVD
151–158 F-DNEETF
176–184 PE-LFF-KR
203–209 LP-LDEL
229–235 KFGER-F
246–263 RFPKAEFAEVSKLV- -LT
320–338 DEMPADLP-L-ADFVE-KD
398–408 FDEFKP- -EEP
419–428 FE-LGEY-FQ
449–455 EVSRNLG
515–521 LEVDETY
540–547 LSEKE-QI
566–575 E-LKA- -DDF
586–595 DD-ETC- -EE
doi:10.1371/journal.pone.0168453.t002
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The algorithm has been made available as a webserver. It takes quantitative peptide data of
fully or partially substituted overlapping peptides as well as protein sequence(s) in FASTA-for-
mat as input. Furthermore, options for specifying a custom significance level and length of
peptides to be analyzed are available. The webserver outputs a table of overlapping peptides,
each with their identified epitope residues highlighted, similar to Table 1, as well as sequence
logos illustrating the specificity of the antibody-epitope complexes; see Fig 5 for details.
Discussion
Insight into antibody-specificity of the binding sites (epitopes) of target proteins is important
for the identification and design of diagnostic targets as well as characterization of therapeutic
antibodies. Through the ability to express large numbers of peptides, the recent advances in
high-density peptide microarrays facilitate high-throughput discovery of linear antibody epi-
topes. The large number of results calls for an automated method for analysing antibody-speci-
ficity. Here, we present a statistical approach to analyze antibody-specificity of epitopes from
peptide-based single amino acid substitution data.
The pipeline is fully automated and consist of three main steps: i) mapping of peptides to
the original target, ii) mapping of epitope positions of individual peptides by determining the
statistical significance of substitutions and iii) determine the selectivity of each target residue
involved in the epitope and visualize this by sequence logos. Using peptide microarray data
containing a complete substitution analysis of HSA the tool was used to identify and character-
ize the specificity of 18 linear epitope regions of polyclonal rabbit anti-HSA antibodies.
The high-resolution substitution analysis allows the user to distinguish close-proximity epi-
topes of polyclonal antibodies, by viewing the epitope mapping in overlapping peptides sliding
through the protein sequence analyzed, as exemplified in Table 1. Here, we illustrate how the
method can deconvolute the presence of four individual antibody epitopes; when part of the
high-signal epitope LVNEVTEF, starting at position 66, leaves the query peptide, the weaker,
but overlapping epitope TEF-KT-V—E is revealed. When the N-terminal of this epitope leaves
the query peptide window another overlapping epitope C-ADESAE-C appears, and yet
another after this one. Identifying these epitopes solely from a signal profile, where only the
signals of entire 15-mers are known, would be a challenge.
As thoroughly discussed by Buus et al. [10] the signal intensity is determined by a number
of factors other than antibody affinity, such as peptide purity, solvation and antibody concen-
tration. Moreover, it is often assumed that high-affinity antibodies are likely to be more spe-
cific, but affinity and specificity are not necessarily linked, as thoroughly discussed by
Regenmortel [1]. Selecting epitope candidates purely on the basis of microarray binding signal
may lead to relevant candidates bring discarded. As a demonstration, the epitope LSEKERQI,
spanning the 540–547 region of HSA are presented in multiple peptides with a relatively weak
signal of (114–170 Au), but the antibody specificity towards this epitope is comparable the that
of the epitope LEVDETY in the signal range of 500 Au, see Fig 5.
When addressing specificity a word of caution is appropriate. The six CDRs of an antibody
harbour multiple overlapping paratopes of 10–20 amino acids, and for an antibody to be
monospecific to a single epitope it would require that the remaining part of the CDRs are
unable to bind any other antigenic structure, which is unlikely [1]. The antibody may appear
monospecific, however, only when tested for their capacity to bind one antigen and not
another. Characterizing the specificity of antibody-epitope interaction by the degree of stereo-
chemical complementarity upon single-amino acid substitutions may assist the selection of
antibodies from polyclonal samples and understanding of the interaction of monoclonal
antibodies.
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There is considerable difference in selectivity between individual residues of the epitopes.
Most epitopes identified here, contain a core of 3–4 highly selective residues and few residues
where a certain chemical property is preferred. This information may prove crucial when char-
acterizing potential cross reactivity to related targets. The logo-plots from the algorithm serve
as a visual representation of the selectivity of individual epitope residues. Here, they have been
used to identify the boundaries of epitope regions in the protein, as seen in Table 2.
One may find a few inconsistencies between the epitopes identified from individual pep-
tides in Table 1 and the interpretation of selectivity by the logo-plots. A word of caution is
hence appropriate, since the two analyses differ in representation of substitutions. While the
PSSM of individual peptides is used to infer peptide positions significantly affected by substitu-
tions, the substitutions of one position (column in the PSSM) with different amino acids may
vary greatly, depending on the physiochemical properties of the replacing amino acid. As
such, the different substitutions in the same peptide position may contribute a higher variance
(and thus higher LSD) to the analysis, than multiple copies of the same replacing amino acid,
consequently leading to false-negative epitope-positions. In the statistical analyses forming the
basis of the logo-plots the pooled variance is calculated from copies of the same replacing
amino acid, but represented in different peptide positions. Here, bias occurs when one protein
position is represented in two overlapping epitopes, interacting with different antibodies. We
strongly suggest that the two analyses outputs should be used in complement to each other.
In conclusion, we have presented an online analysis tool for automated characterization and
visualization of antibody selectivity toward specificity-determining epitope residues from pep-
tide microarray-driven substitution analysis. Although the method was developed with the aim
of characterizing antibody-peptide interactions, it is not restricted to such interactions, but can
readily analyse quantitative peptide data from any receptor-ligand interaction, provided that
single-amino acid derivative peptides of the ligand peptides exist. We expect this application to
be useful in complete substitution analysis of pre-identified binding peptides from multiple pro-
teins, such as complete linear antibody epitope mapping of entire proteomes.
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S1 Fig. Selectivity profile of HSA epitopes. Logo-plot representations of the selectivity of epi-
tope regions of HSA. Selectivity is determined by Dunnett’s test on all substitutions of target
position, being represented in overlapping peptides. Each letter represents replacing amino
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at the p<0.0001 level) are highlighted whereas dashes indicate positions not involved in bind-
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